The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid.

Abstract
In this study, we use antisera to synthetic .beta.-amyloid protein precursor (.beta.APP) peptides to identify, in human brain and cerebrospinal fluid (CSF), soluble .apprxeq. 125- and .apprxeq. 105-kDa derivatives of the .beta.APP that lack the carboxyl terminus of the full-length, membrane-associated forms. We show that the soluble .apprxeq. 125-kDa .beta.APP derivative contains the Kunitz protease inhibitor domain, whereas the .apprxeq. 105-kDa form does not, and we confirm that these two proteins are soluble .beta.APP derivatives by purifying each from human CSF and directly sequencing its amino terminus.